Categories

Above the Fold

HEALTH PLANS: Oops my bad, Aetna’s not overpaying Rowe after all

You may recall a while back that I was a tad critical of Aetna for paying Jack Rowe $18 million for his efforts in 2003. They claimed of course that they had to keep his compensation competitive to keep him there. And of course events have proved them right. Why at any moment he’s likely to jump ship to Anthem, who yesterday announced that their CEO Larry Glasscock, in addition to his paltry $3m base salary for 2003, is going to get a $21m cash bonus and another $21m in stock vesting in the next 2 years. If I was Rowe, I’d be dragging the Aetna board back from the ski slopes (or wherever they are) and asking where they put the extra $28m he surely needs to keep him from taking over from Glasscock.

Assuming of course that Glasscock wants to sail off into the sunset rather than hang out in the new and improved Anthem with Len Schaeffer second guessing his every move.

PHARMA: The re-import battle that will not die

Surely big pharma can put together an organized retreat on this re-import issue. All they have to do is allow the FDA to announce that they will allow imports, have them promise to report back on how some time after November, and take this issue off the table. As I’ve said before, it’s just not a big financial deal for them right now, and probably won’t be for a while. But instead they insist on trotting out a case that no one other than they and the Surgeon-General believes. Did they not read these polls showing 79% of seniors disapproving of their position? I’m sure my friends at Harris will be happy to share more results with them for a small fee!

TECHNOLOGY: New York Times CPOE article

Milt Freudenheim has an article in the New York Times about the trouble that hospitals are having with computerized patient care. Well worth a read, even though the numbers about the current low use of CPOE and relatively low planned use of CPOE are well known in the academic press and I’ve blogged about them before.

The important part of the Times article is the fact that the public is getting a wider understanding of the slow progress health care is making. But it is making progress (finally) and according to the Gartner numbers in the NY Times article larger hospitals show remarkable progress in the number who are implementing CPOE and planning to implement it.

POLICY: Health care lobbyists pay up, get their money’s worth

In a recent study originally in JAMA, it was shown that health care companies put $237m into lobbying in the year 2000. 2000 was you may recall the year of a somewhat controversial and close election. Of the money

    Drug companies and medical supply companies together spent $96m. Physicians and other health professionals, such as nurses, spent $46m, hospitals and nursing homes $40m, health insurance and managed care companies $31m, and disease advocacy and public health organizations spent $12m. During the study period, 1997-2000, spending on lobbying by health professionals grew by only 10% compared with 26% by other organizations.

Given that the recent Medicare bill returned big increases in Medicare fees (or at least overturned planned reductions) for both physicians and hospitals, increased Medicare payments for health plans, and of course added billions in potential new government revenue to pharma companies, I’d say the money was well spent.

OK, so that’s cynical, but the current state of US campaign and electoral financing is that all politicians need money, mostly for TV advertising. Those who contribute get their issues heard. And the health care industry is merely doing the logical thing.

HOSPITALS: Emergency departments and how hospitals make money. With UPDATE late afternoon 4/6/04

There’s a very interesting new(ish) and counter-intuitive web-only article out in Health Affairs from USC and RAND health economist Glen Melnick about emergency department (ED) capacity in California. The conventional wisdom is that emergency departments at hospitals are flooded with the uninsured, they on average lose money on their patients, and the prevailing trend is for the hospitals to close their EDs if they can get away with it. Melnick’s team looked at a decade’s worth of data from the state and found that:

    ED capacity, measured in terms of beds, expanded 20 percent over the twelve-year period, while the population rose 16.3 percent and visits increased 13.4 percent. As a result, ED beds per 100,000 population grew over the period. . . the percentage of hospitals with an ED at the beginning and end of each of the six-year periods. . . fell only slightly.

Although the total number of EDs declined, most of those closings were by-products of total hospital closings rather than specific closings by hospitals getting out of the market. So why was the conventional wisdom wrong? Not because hospitals made money on their ED “outpatient” visits–they lost money on their EDs on average. How come they then weren’t closing EDs in droves, with appalling consequences for access to health services for the poor and the availability of emergency care for all of us?

Two main reasons. The big hospitals that couldn’t politically afford to close their EDs because they are a major source of outpatient care in their communities (poster-child here being LA County of course) received enough money via the DSH program in Medicaid to stay alive. The rest of them were making so much money through providing inpatient services to the people admitted via the ED which accounted for 40% of all admissions, that they could afford to run the ED as a loss leader. And of course, though it’s politically incorrect to say it, hospitals have the ability to discover the insurance status of those coming in the ED in advance of admitting them to an inpatient bed.

In other words, the ED is being used as a quasi-screening program. Hospitals run these screening programs all the time trawling for people in the community who might legitimately need their services. CPM is well regarded consumer marketing company that helps them do just that. Hospitals make so much money on admitting a well-insured patient for an invasive procedure that it’s worth the cost of screening many “negatives”, in say cardiology, many times over if it generates a well-paying “positive” admission. Of course hospitals are also interested in reducing their levels of bad debt from non-paying ED patients, and this delicate balance of providing care to the needy and at the same time getting hold of the well-paying admission is being played out across the country every day.

Interestingly enough, several other loss-leaders also exist in the hospital world. As this article makes clear, hospitalists don’t generate enough fees to cover the cost of employing them but they improve the throughput of a hospital by getting DRG-based patients to discharge earlier, and increase admissions by improving the lives of admitting physicians. So overall hospitalist programs improve the hospitals bottom line and so are growing. So like the ED situation, any one aspect of the economics of a hospital must be assessed in the overall scheme of how hospitals make money. And the way hospitals make money is by filling their key service lines with patients that need services and have decent insurance to pay for it.

UPDATE: ED doc Doug Evans points out to me that the response article to the Melnick study from ACEP President Wes Fields shows that most of the bed growth related to ED admissions is in the wealthier suburban hospitals, while the inner city hospitals have EDs that are increasingly over-crowded and offering poor primary care. Ambulance diversions and other mal-effects of ED overuse are on the rise according to Kellerman, Duaner, and Siegel. None of this means that, given the hand that they’ve been dealt, hospitals shouldn’t try to make money via their EDs. It also doesn’t mean that we ought to have a health “system” that doesn’t provide insurance coverage to 15% of the population and dumps that care on a handful of inner city hospitals. I think Melnick agrees.

INDUSTRY: Consolidation in the health care sector

Today looks like a big day for more consolidation. Big drug chain CVS is getting bigger by buying part of the Eckerd chain owned by JC Penny. The other part is being bought by Canadian chain Jean Coutu Group.

In the health plan sector Oxford Health Plans is up 10% up on strong rumors that it will be bought by Wellchoice, the for-profit company that used to be Empire Health Plans, the New York City Blues plan. This is an interesting one, as it may be the first time that a Blues plan has gone outside the Blues system for an aquistion. Almost every other Blues plan has grown by aquiring other Blues, with the Anthem/Wellpoint merger being the latest example.

PERSONAL/QUALITY: Knee surgery update

So I had arthroscopic surgery at a Healthsouth facility from a Brown & Toland surgeon on Friday. The admin staff and the nursing staff were superb, and the majority of my information from the physician’s office had in fact got over to the surgi-center, so there was no need for me to repeat everything. They also allowed me to not pay anything up front, as I explained that I thought my previous office visits and MRI would take up all my deductible and out of pocket. I even have a new MSA (should be HSA) card from the "MSA Bank" which I should be able to use to make those payments tax-free. So I am now one of those health care consumers I’ve been warning you about!

The surgery was in some ways rather fun, particularly as it was minor enough that I was able to be woken up after a quick general anesthetic and was able to watch the monitor as it happened. I could see a huge drill blasting the odd bit of white scar tissue, and although there was a cloth barrier stopping me from seeing the surgeon, I was even able to get the nurse to bring it down by joking that I was watching a tape from another surgery. But there he was slicing/drilling away, and describing to me what he was doing. I’ve since told several people about this but none of them seemed to be anything other than queasy.

The most amazing thing is that although I had a couple of Percocet in the facility, I have taken none of the Vicodin I thought I’d need over the past 48 hours. The knee is pretty swollen, but I can already walk OK–it’s stiff but not painful. Hopefully in a couple of weeks I’ll be better than before. I’ll keep you in touch, but going through this experience is always interesting for those of us in the health care business who don’t often see things from the "business" end!

By the way, if you don’t know the history, the surgery was follow up to much more significant knee surgery 2 years ago when I had ACL/PCL grafts following a violent snowboarding accident.

PERSONAL: Back on the slab

By the time most of you read this, I’ll be on the table having yet more knee surgery (An arthroscopy to repair cartilage and scar tissue following my ACL/PCL repair 2 years ago). I’ll report back Monday about how it went, and hopefully I’ll get a last snowboarding run in before all the snow melts.

QUALITY: Malpractice Jury-Award Median Up Slightly

A new study out from Jury Verdict Research shows that the median malpractice award for 2002 was stuck at $1m–no real increase from 2001. The proportion of successful cases brought against doctors went up slightly but was still only 42%. This is though up from 29% in 1996. Although the denominator is not in this report, the total amount awarded was estimated at $4.2 billion in 2002 according to these data from the National Practitioner Databank. The figures disagree from Jury Research’s in that in 2002 the National Practitioner Databank estimated that there were 452 awards for a median of $286K and a mean of $506K (implying some 650 odd cases that made it to court and were won by the defendant physician). But in any even the vast majority of the $4.2 billion handed over was in settlements, of which there were 14,852 in 2002. In other words around 7% of cases make it to court, and around 15,000 cases end up with money paid to the plaintiff each year.

Given that there are around 550,000 practicing doctors in the US, this means that roughly 3% are in some way being successfully sued for malpractice each year. When you look at it that way, it’s not that big a problem. (Cue barrage of email, no doubt!).

POLICY/QUALITY: Antibiotics overuse as an emerging public health threat

THCB is now so influential that people are seeking to advertise on it. Really! (Stop that sniggering). I did get a message from John Riley at Keep Antibiotics Working to ask if he could advertise to my readers. As this site is designed to produce neutral but opinionated reporting (that advertises only me and my services as a by-product) and also I’m not set up to take advertising, I declined. But after I saw what the site was about and read this post from Family Medicine Notes about the dangers of antibiotic overuse in humans, I thought that it would be worth giving John some space to explain why antibiotic overuse in animals is such a health and policy problem. So here’s his argument:

    Over the last 60 years, effective antibiotics have turned bacterial infections into treatable conditions, rather than the life-threatening scourges they once were. The effectiveness of many life-saving antibiotics is, however, waning. Health experts have deemed the rise in antibiotic resistance a public health crisis. Everyone is at risk from antibiotic-resistant infections, but children, the elderly, and people with weakened immune systems are particularly vulnerable.

    The overuse of antibiotics is to blame. A major source of this overuse is routine use of antibiotics as feed additives for livestock and poultry–not to treat disease, but instead to promote growth and compensate for crowded, stressful, unsanitary conditions. The Union of Concerned Scientists estimates that 70% of all antibiotics in the U.S. are used as feed additives for pigs, poultry and cattle. In June 2001, the American Medical Association went on record opposing the routine feeding of medically important antibiotics to livestock and poultry (i.e., “nontherapeutic” use).

    Antibiotic use in animal agriculture has been linked definitively to human bacterial infections resistant to antibiotics. Mounting evidence suggests that widespread overuse of agricultural antibiotics also may be contaminating surface waters and groundwater, including drinking water sources in many rural areas. Nonetheless, agribusiness and the pharmaceutical industry are fighting hard to thwart restrictions on the use of antibiotics in agriculture.
    While medical use of antibiotics is a major contributor to the emergence of antibiotic resistance, agricultural uses also pose a significant problem since they promote the development of resistant bacteria that can reach humans through several different pathways – directly via contaminated food or indirectly via environmental contamination.

    In an effort to curb the spread of resistant bacteria and protect the efficacy of antibiotic drugs, the “Preservation of Antibiotics for Medical Treatment Act” (S. 1460/H.R. 2932) is bipartisan legislation pending in both houses of Congress that would phase out the routine use of eight classes of medically important antibiotics in animal agriculture, unless their use can be shown not to pose a threat to human health. The legislation would continue to allow antibiotic use for treating sick animals and preventing the spread of documented illnesses in a flock or herd. Over 325 organizations around the country have endorsed this legislation, including 83 professional health groups, such as the American Medical Association and the American Public Health Association.

    Keep Antibiotics Working, a coalition of health, consumer, agricultural, environmental and other advocacy groups with over 9 million members, is seeking individuals who have experienced an antibiotic-resistant illness to share their stories and help protect the effectiveness of antibiotics. For more information, please visit www.KeepAntibioticsWorking.com.

assetto corsa mods